1-4 of 4
Shireen Sirhan, MD, FRCP
Close
Sort by
Journal Articles

Circulating Cytokines and Markers of Iron Metabolism in Myelofibrosis Patients Treated with Momelotininb: Correlatives from the Ym-387-II Study

Vikas Gupta, MD FRCP, FRCPath, Ruben A. Mesa, Michael W Deininger, MD PhD, Candido E. Rivera, MD, Shireen Sirhan, MD FRCP, Srdan Verstovsek, MD, Yafeng Zhang, PhD, Yuanyuan Xiao, PhD, Helen Collins, MD, Kevin Kwei, Adarsh Joshi, PhD, Carrie Baker Brachmann, PhD
Journal: Blood
Blood (2015) 126 (23): 1600.
https://doi.org/10.1182/blood.V126.23.1600.1600
Published: 2015
Journal Articles

Update On The Long-Term Efficacy and Safety Of Momelotinib, a JAK1 and JAK2 Inhibitor, For The Treatment Of Myelofibrosis

Animesh Pardanani, MBBS, PhD, Jason Gotlib, MD, MS, Vikas Gupta, MD, FRCP, FRCPath, Andrew W. Roberts, MBBS, PhD, Martha Wadleigh, MD, Shireen Sirhan, MD, FRCP, Linda M Bavisotto, MD, Jun Kawashima, MD, Peter Lee, MD, PhD, Mark Kowalski, MD, PhD, Wei Deng, PhD, Demi Niforos, MS, Ayalew Tefferi, MD
Journal: Blood
Blood (2013) 122 (21): 108.
https://doi.org/10.1182/blood.V122.21.108.108
Published: 2013
Journal Articles

Phase I/II Study of CYT387, a JAK1/JAK2 Inhibitor for the Treatment of Myelofibrosis

Animesh Pardanani, MBBS, PhD, Jason Gotlib, Vikas Gupta, MD, FRCP, FRCPath, Andrew W. Roberts, MBBS, PhD, Martha Wadleigh, MD, Shireen Sirhan, MD, FRCP, Linda M Bavisotto, MD, Jun Kawashima, MD, Mark Kowalski, MD, PhD, Ayalew Tefferi, MD
Journal: Blood
Blood (2012) 120 (21): 178.
https://doi.org/10.1182/blood.V120.21.178.178
Published: 2012
Journal Articles

An Expanded Multicenter Phase I/II Study of CYT387, a JAK- 1/2 Inhibitor for the Treatment of Myelofibrosis,

Animesh Pardanani, MBBS, PhD, Jason Gotlib, M.D., M.S., Vikas Gupta, MD, FRCP, FRCPath, Andrew W Roberts, MBBS, PhD, Martha Wadleigh, MD, Shireen Sirhan, MD, FRCP, Mark R. Litzow, MD, William J Hogan, MBBCh, Kebede Begna, MD, Gregg Smith, PhD, MBA, Linda M Bavisotto, MD, Mark Kowalski, MD, PhD, Ayalew Tefferi, MD
Journal: Blood
Blood (2011) 118 (21): 3849.
https://doi.org/10.1182/blood.V118.21.3849.3849
Published: 2011